BlackRock Fund Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$61,952,000
-41.4%
2,258,531
+31.2%
0.01%
-50.0%
Q3 2016$105,745,000
+245.3%
1,721,948
+7.2%
0.02%
+214.3%
Q2 2016$30,624,000
-5.6%
1,605,847
-3.4%
0.01%
-12.5%
Q1 2016$32,439,000
-48.3%
1,661,818
+2.2%
0.01%
-42.9%
Q4 2015$62,710,000
+24.4%
1,625,447
+3.5%
0.01%
+7.7%
Q3 2015$50,413,000
+8.4%
1,570,016
+2.7%
0.01%
+18.2%
Q2 2015$46,522,000
+124.4%
1,528,833
-2.1%
0.01%
+120.0%
Q1 2015$20,730,000
-5.5%
1,560,992
+3.0%
0.01%0.0%
Q4 2014$21,932,000
-24.8%
1,515,691
+9.7%
0.01%
-37.5%
Q3 2014$29,146,000
-29.6%
1,381,334
-0.7%
0.01%
-33.3%
Q2 2014$41,427,000
+22.3%
1,390,644
-1.3%
0.01%
+20.0%
Q1 2014$33,873,000
+22.0%
1,409,614
+3.4%
0.01%
+25.0%
Q4 2013$27,767,000
-52.1%
1,363,153
+11.1%
0.01%
-60.0%
Q3 2013$57,947,000
+49.7%
1,226,911
+20.6%
0.02%
+42.9%
Q2 2013$38,708,0001,017,5930.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders